Head of Marketing - RayzeBio jobs in United States
cer-icon
Apply on Employer Site
company-logo

Bristol Myers Squibb · 17 hours ago

Head of Marketing - RayzeBio

Bristol Myers Squibb is a leading biopharmaceutical company focused on transforming patients' lives through science. They are seeking a Head of Marketing for RayzeBio, who will lead the global brand and launch strategy for their first commercial product, RYZ101, and drive commercial readiness from NDA through launch and early lifecycle growth.

BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
check
H1B Sponsor Likelynote

Responsibilities

Lead the global commercial marketing strategy for RYZ101, defining positioning, messaging architecture, segmentation, and differentiation—translating clinical evidence into compelling customer value
Develop and execute the integrated pre-launch and launch roadmap, ensuring global-to-local alignment and clear decision points across key workstreams
Lead cross-functional NDA readiness activities, ensuring labeling, promotional readiness, and market access strategies are aligned with commercial goals and launch scenarios
Develop and manage the commercial launch scorecard and key performance indicators to track organizational readiness, identify gaps early, and accelerate issue resolution
Drive pre-launch market shaping, including disease education, stakeholder engagement, and thought leader (TL) partnership initiatives in collaboration with Medical Affairs
Partner with Market Access and Patient Services to ensure payer, reimbursement, and patient support strategies reflect real-world patient journeys and site-of-care workflows
Work with the Commercial Operations and Strategy Lead to drive health-system and site enablement strategies for nuclear medicine centers, integrating operational and logistical requirements unique to radiopharmaceuticals
Oversee creative agencies and promotional partners, ensuring best-in-class omnichannel execution (digital, web, CRM, field enablement) and effective medical/legal/regulatory (MLR) review outcomes
Establish and scale modern, AI-enabled marketing capabilities—e.g., faster insight synthesis, audience and journey analytics, predictive signals for adoption, modular content systems, compliant GenAI-assisted drafting, and rapid test-and-learn experimentation with clear measurement
Build and lead a high-performing marketing team and establish launch excellence standards and repeatable playbooks for RayzeBio’s future pipeline assets
Represent Marketing in governance forums and ensure business continuity between NDA filing and post-approval launch execution, maintaining pace, clarity, and alignment across the matrix (including BMS)

Qualification

Oncology MarketingCommercial Launch StrategyRadiopharmaceutical CommercializationMarket Access StrategiesAI-Enabled MarketingCross-Functional LeadershipAnalytical SkillsStrategic PlanningCommunication SkillsTeam Leadership

Required

Bachelor's degree required; advanced degree (MBA, PharmD, PhD) is a plus
Minimum 10 years of experience in pharmaceutical or biotechnology commercialization leadership roles, with significant experience in oncology marketing and multiple product launches
Proven success leading cross-functional launch planning and execution, including pre-launch and post-launch phases
Demonstrated ability to lead through influence, work across matrixed teams, and operate effectively at the executive level
Knowledge of healthcare system dynamics, payer environments, and site-of-care considerations relevant to nuclear medicine and oncology
Exceptional analytical, strategic, and operational planning skills with the ability to synthesize complex information into actionable insights
Exceptional communication, presentation, and stakeholder management skills

Preferred

Leadership experience in radiopharmaceutical commercialization is highly preferred
Experience with first-to-market, novel therapeutic launches or complex modality launches (radiopharmaceuticals, cell/gene therapy, or other infrastructure-dependent products) is a plus
Comfort with modern marketing analytics and AI-enabled approaches (e.g., experimentation, personalization, next-best-action thinking, and performance measurement), applied responsibly with appropriate governance

Benefits

Health Coverage: Medical, pharmacy, dental, and vision care.
Wellbeing Support: Programs such as BMS Well-Being Account, BMS Living Life Better, and Employee Assistance Programs (EAP).
Financial Well-being and Protection: 401(k) plan, short- and long-term disability, life insurance, accident insurance, supplemental health insurance, business travel protection, personal liability protection, identity theft benefit, legal support, and survivor support.
Paid Time Off: US Exempt Employees: flexible time off (unlimited, with manager approval, 11 paid national holidays (not applicable to employees in Phoenix, AZ, Puerto Rico or Rayzebio employees)
Phoenix, AZ, Puerto Rico and Rayzebio Exempt, Non-Exempt, Hourly Employees: 160 hours annual paid vacation for new hires with manager approval, 11 national holidays, and 3 optional holidays
Based on eligibility, additional time off for employees may include unlimited paid sick time, up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence for medical, personal, parental, caregiver, bereavement, and military needs and an annual Global Shutdown between Christmas and New Years Day.

Company

Bristol Myers Squibb

company-logo
At Bristol Myers Squibb, we work every day to transform patients’ lives through science.

H1B Sponsorship

Bristol Myers Squibb has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (247)
2024 (278)
2023 (231)
2022 (180)
2021 (181)
2020 (169)

Funding

Current Stage
Public Company
Total Funding
$29.32B
Key Investors
Venrock
2025-11-05Post Ipo Debt· $5.74B
2024-02-14Post Ipo Debt· $13B
2023-10-30Post Ipo Debt· $4.5B

Leadership Team

leader-logo
Charles Bancroft
CFO
linkedin
leader-logo
Cristian Massacesi
Executive Vice President, Chief Medical Officer and Head of Development
linkedin
Company data provided by crunchbase